BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8289369)

  • 1. A small and efficient dimerization/packaging signal of rat VL30 RNA and its use in murine leukemia virus-VL30-derived vectors for gene transfer.
    Torrent C; Gabus C; Darlix JL
    J Virol; 1994 Feb; 68(2):661-7. PubMed ID: 8289369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
    Torrent C; Wang P; Darlix JL
    Bone Marrow Transplant; 1992; 9 Suppl 1():143-7. PubMed ID: 1324044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus.
    Torrent C; Bordet T; Darlix JL
    J Mol Biol; 1994 Jul; 240(5):434-44. PubMed ID: 8046749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors.
    Berlioz C; Torrent C; Darlix JL
    J Virol; 1995 Oct; 69(10):6400-7. PubMed ID: 7666541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient packaging of a specific VL30 retroelement by psi 2 cells which produce MoMLV recombinant retroviruses.
    Hatzoglou M; Hodgson CP; Mularo F; Hanson RW
    Hum Gene Ther; 1990; 1(4):385-97. PubMed ID: 1964095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition.
    D'Souza V; Melamed J; Habib D; Pullen K; Wallace K; Summers MF
    J Mol Biol; 2001 Nov; 314(2):217-32. PubMed ID: 11718556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable MLV-VL30 dicistronic retroviral vectors with a VL30 or MoMLV sequence promoting both packaging of genomic RNA and expression of the 3' cistron.
    Torrent C; Berlioz C; Darlix JL
    Hum Gene Ther; 1996 Mar; 7(5):603-12. PubMed ID: 8845385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
    Chakraborty AK; Zink MA; Hodgson CP
    Cancer Gene Ther; 1994 Jun; 1(2):113-8. PubMed ID: 7621242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an internal ribosome entry segment in the 5' region of the mouse VL30 retrotransposon and its use in the development of retroviral vectors.
    López-Lastra M; Ulrici S; Gabus C; Darlix JL
    J Virol; 1999 Oct; 73(10):8393-402. PubMed ID: 10482590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of homo- and heterodimerization of Harvey sarcoma virus RNA by GACG tetraloops and point mutations in palindromic sequences.
    Rasmussen SV; Mikkelsen JG; Pedersen FS
    J Mol Biol; 2002 Nov; 323(4):613-28. PubMed ID: 12419254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.
    Yu Q; Darlix JL
    J Virol; 1996 Sep; 70(9):5791-8. PubMed ID: 8709195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The packaging signal of MLV is an integrated module that mediates intracellular transport of genomic RNAs.
    Basyuk E; Boulon S; Skou Pedersen F; Bertrand E; Vestergaard Rasmussen S
    J Mol Biol; 2005 Nov; 354(2):330-9. PubMed ID: 16253274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA.
    Prats AC; Roy C; Wang PA; Erard M; Housset V; Gabus C; Paoletti C; Darlix JL
    J Virol; 1990 Feb; 64(2):774-83. PubMed ID: 2153242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forced recombination of psi-modified murine leukaemia virus-based vectors with murine leukaemia-like and VL30 murine endogenous retroviruses.
    Mikkelsen JG; Lund AH; Duch M; Pedersen FS
    J Gen Virol; 1999 Nov; 80 ( Pt 11)():2957-2967. PubMed ID: 10580058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination.
    Goldfarb MP; Weinberg RA
    J Virol; 1981 Apr; 38(1):136-50. PubMed ID: 7241647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harvey murine sarcoma virus/MDR1 retroviral vectors: efficient virus production and foreign gene transduction using MDR1 as a selectable marker.
    Metz MZ; Best DM; Kane SE
    Virology; 1995 Apr; 208(2):634-43. PubMed ID: 7747435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
    Patience C; Takeuchi Y; Cosset FL; Weiss RA
    J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of retroviral RNA packaging.
    Aronoff R; Linial M
    J Virol; 1991 Jan; 65(1):71-80. PubMed ID: 1985218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.
    Bender MA; Palmer TD; Gelinas RE; Miller AD
    J Virol; 1987 May; 61(5):1639-46. PubMed ID: 3502707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.
    Certo JL; Kabdulov TO; Paulson ML; Anderson JA; Hu WS
    J Virol; 1999 Nov; 73(11):9170-7. PubMed ID: 10516024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.